Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fibroblast growth factor-2: an endogenous antidepressant and anxiolytic molecule?

Literature DB >> 22840947

Fibroblast growth factor-2: an endogenous antidepressant and anxiolytic molecule?

Cortney A Turner¹, Stanley J Watson, Huda Akil.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2012 PMID： 22840947 PMCID： PMC4417938 DOI： 10.1016/j.biopsych.2012.05.025

Source DB: PubMed Journal: Biol Psychiatry ISSN： 0006-3223 Impact factor: 13.382

× No keyword cloud information.

10 in total

1. Fibroblast growth factor-2 (FGF2) augmentation early in life alters hippocampal development and rescues the anxiety phenotype in vulnerable animals.

Authors: Cortney A Turner; Sarah M Clinton; Robert C Thompson; Stanley J Watson; Huda Akil
Journal: Proc Natl Acad Sci U S A Date: 2011-04-25 Impact factor: 11.205

2. Toward a novel endogenous anxiolytic factor, fibroblast growth factor 2.

Authors: Natalina Salmaso; Flora M Vaccarino
Journal: Biol Psychiatry Date: 2011-03-15 Impact factor: 13.382

3. Short-hairpin RNA silencing of endogenous fibroblast growth factor 2 in rat hippocampus increases anxiety behavior.

Authors: Emine Eren-Koçak; Cortney A Turner; Stanley J Watson; Huda Akil
Journal: Biol Psychiatry Date: 2011-01-07 Impact factor: 13.382

4. Antidepressant effects of fibroblast growth factor-2 in behavioral and cellular models of depression.

Authors: Maha Elsayed; Mounira Banasr; Vanja Duric; Neil M Fournier; Pawel Licznerski; Ronald S Duman
Journal: Biol Psychiatry Date: 2012-04-17 Impact factor: 13.382

5. Antidepressant treatments induce the expression of basic fibroblast growth factor in cortical and hippocampal neurons.

Authors: Alessandra Mallei; Bitao Shi; Italo Mocchetti
Journal: Mol Pharmacol Date: 2002-05 Impact factor: 4.436

6. Dysregulation of the fibroblast growth factor system in major depression.

Authors: S J Evans; P V Choudary; C R Neal; J Z Li; M P Vawter; H Tomita; J F Lopez; R C Thompson; F Meng; J D Stead; D M Walsh; R M Myers; W E Bunney; S J Watson; E G Jones; H Akil
Journal: Proc Natl Acad Sci U S A Date: 2004-10-13 Impact factor: 11.205

7. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

Authors: R C Kessler; K A McGonagle; S Zhao; C B Nelson; M Hughes; S Eshleman; H U Wittchen; K S Kendler
Journal: Arch Gen Psychiatry Date: 1994-01

8. Antidepressant-like effects of intracerebroventricular FGF2 in rats.

Authors: Cortney A Turner; Edny L Gula; Larry P Taylor; Stanley J Watson; Huda Akil
Journal: Brain Res Date: 2008-06-14 Impact factor: 3.252

9. The fibroblast growth factor system is downregulated following social defeat.

Authors: Cortney A Turner; Nelson Calvo; Douglas O Frost; Huda Akil; Stanley J Watson
Journal: Neurosci Lett Date: 2007-11-06 Impact factor: 3.046

10. A new role for FGF2 as an endogenous inhibitor of anxiety.

Authors: Javier A Perez; Sarah M Clinton; Cortney A Turner; Stanley J Watson; Huda Akil
Journal: J Neurosci Date: 2009-05-13 Impact factor: 6.167

10 in total

4 in total

1. Fibroblast growth factor 2 alters the oxytocin receptor in a developmental model of anxiety-like behavior in male rat pups.

Authors: Yoav Litvin; Cortney A Turner; Mariel B Rios; Pamela M Maras; Sraboni Chaudhury; Miriam R Baker; Peter Blandino; Stanley J Watson; Huda Akil; Bruce McEwen
Journal: Horm Behav Date: 2016-09-28 Impact factor: 3.587